http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AT-395817-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06e04d8c0e03f7238fca9dee03e6e6b9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-65 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65 |
| filingDate | 1991-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1993-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AT-395817-B |
| titleOfInvention | DRUGS AGAINST LYSSA |
| abstract | The use of a combination of doxycycline and choline chloride and/or choline citrate, preferably of 98% doxycycline and 2% choline chloride, for producing a medicine for treating rabies is described. |
| priorityDate | 1991-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.